EMA Recommends Extension of Indications for Dostarlimab By Ogkologos - January 23, 2025 565 0 Facebook Twitter Google+ Pinterest WhatsApp Change concerns the first-line treatment of patients with endometrial cancer Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR ESMO’s Expert Consensus: Do Not Discontinue or Delay Cancer Treatment That... July 31, 2020 Trastuzumab Deruxtecan in Second-Line Treatment for Patients with HER2-positive Advanced Gastric... July 5, 2023 Researchers Have Harnessed a Compound from a Common Plant Called Feverfew... August 2, 2019 Many Patients with NSCLC Show Targetable Alterations in the PI3K Pathway March 24, 2021 Load more HOT NEWS Doctor Said Her Mammogram Results Were Normal, But Now She’s Fighting... Cancer in My Community: Providing Free Access to Cancer Care in... T-DM1 is Active and Well Tolerated in Patients with HER2-positive Metastatic... Patient Guide on Immunotherapy Side Effects and Their Management Now Available...
